- call +1-201-465-4211
- email sales@mrinsights.biz
5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - 5'-Nucleotidase (5NT) is an intrinsic membrane glycoprotein that is present as an enzyme in a wide variety of mammalian cells. It catalyzes the phosphorylytic cleavage of 5'nucleotides.
Scope of the Report:
Colorectal Cancer, Fallopian Tube Cancer, Gastric Cancer, Metastatic Colorectal Cancer, Others are dominant players in the global 5 Nucleotidase market.
The global 5'Nucleotidase market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of 5'Nucleotidase.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the 5'Nucleotidase market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the 5'Nucleotidase market by product type and applications/end industries.
Market Segment by Companies, this report covers
Bristol-Myers Squibb
Corvus Pharmaceuticals
Innate Pharma
MedImmune
Surface Oncology
Vitae Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Single Dose
Combination Therapy
Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgical Centers
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 5'Nucleotidase Market Overview
1.1 Product Overview and Scope of 5'Nucleotidase
1.2 Classification of 5'Nucleotidase by Types
1.2.1 Global 5'Nucleotidase Revenue Comparison by Types (2017-2023)
1.2.2 Global 5'Nucleotidase Revenue Market Share by Types in 2017
1.2.3 Single Dose
1.2.4 Combination Therapy
1.3 Global 5'Nucleotidase Market by Application
1.3.1 Global 5'Nucleotidase Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global 5'Nucleotidase Market by Regions
1.4.1 Global 5'Nucleotidase Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) 5'Nucleotidase Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) 5'Nucleotidase Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 5'Nucleotidase Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) 5'Nucleotidase Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) 5'Nucleotidase Status and Prospect (2013-2023)
1.5 Global Market Size of 5'Nucleotidase (2013-2023)
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Business Overview
2.1.2 5'Nucleotidase Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bristol-Myers Squibb 5'Nucleotidase Revenue, Gross Margin and Market Share (2016-2017)
2.2 Corvus Pharmaceuticals
2.2.1 Business Overview
2.2.2 5'Nucleotidase Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Corvus Pharmaceuticals 5'Nucleotidase Revenue, Gross Margin and Market Share (2016-2017)
2.3 Innate Pharma
2.3.1 Business Overview
2.3.2 5'Nucleotidase Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Innate Pharma 5'Nucleotidase Revenue, Gross Margin and Market Share (2016-2017)
2.4 MedImmune
2.4.1 Business Overview
2.4.2 5'Nucleotidase Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 MedImmune 5'Nucleotidase Revenue, Gross Margin and Market Share (2016-2017)
2.5 Surface Oncology
2.5.1 Business Overview
2.5.2 5'Nucleotidase Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Surface Oncology 5'Nucleotidase Revenue, Gross Margin and Market Share (2016-2017)
2.6 Vitae Pharmaceuticals
2.6.1 Business Overview
2.6.2 5'Nucleotidase Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Vitae Pharmaceuticals 5'Nucleotidase Revenue, Gross Margin and Market Share (2016-2017)
3 Global 5'Nucleotidase Market Competition, by Players
3.1 Global 5'Nucleotidase Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 5'Nucleotidase Players Market Share
3.2.2 Top 10 5'Nucleotidase Players Market Share
3.3 Market Competition Trend
4 Global 5'Nucleotidase Market Size by Regions
4.1 Global 5'Nucleotidase Revenue and Market Share by Regions
4.2 North America 5'Nucleotidase Revenue and Growth Rate (2013-2018)
4.3 Europe 5'Nucleotidase Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific 5'Nucleotidase Revenue and Growth Rate (2013-2018)
4.5 South America 5'Nucleotidase Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa 5'Nucleotidase Revenue and Growth Rate (2013-2018)
5 North America 5'Nucleotidase Revenue by Countries
5.1 North America 5'Nucleotidase Revenue by Countries (2013-2018)
5.2 USA 5'Nucleotidase Revenue and Growth Rate (2013-2018)
5.3 Canada 5'Nucleotidase Revenue and Growth Rate (2013-2018)
5.4 Mexico 5'Nucleotidase Revenue and Growth Rate (2013-2018)
6 Europe 5'Nucleotidase Revenue by Countries
6.1 Europe 5'Nucleotidase Revenue by Countries (2013-2018)
6.2 Germany 5'Nucleotidase Revenue and Growth Rate (2013-2018)
6.3 UK 5'Nucleotidase Revenue and Growth Rate (2013-2018)
6.4 France 5'Nucleotidase Revenue and Growth Rate (2013-2018)
6.5 Russia 5'Nucleotidase Revenue and Growth Rate (2013-2018)
6.6 Italy 5'Nucleotidase Revenue and Growth Rate (2013-2018)
7 Asia-Pacific 5'Nucleotidase Revenue by Countries
7.1 Asia-Pacific 5'Nucleotidase Revenue by Countries (2013-2018)
7.2 China 5'Nucleotidase Revenue and Growth Rate (2013-2018)
7.3 Japan 5'Nucleotidase Revenue and Growth Rate (2013-2018)
7.4 Korea 5'Nucleotidase Revenue and Growth Rate (2013-2018)
7.5 India 5'Nucleotidase Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia 5'Nucleotidase Revenue and Growth Rate (2013-2018)
8 South America 5'Nucleotidase Revenue by Countries
8.1 South America 5'Nucleotidase Revenue by Countries (2013-2018)
8.2 Brazil 5'Nucleotidase Revenue and Growth Rate (2013-2018)
8.3 Argentina 5'Nucleotidase Revenue and Growth Rate (2013-2018)
8.4 Colombia 5'Nucleotidase Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue 5'Nucleotidase by Countries
9.1 Middle East and Africa 5'Nucleotidase Revenue by Countries (2013-2018)
9.2 Saudi Arabia 5'Nucleotidase Revenue and Growth Rate (2013-2018)
9.3 UAE 5'Nucleotidase Revenue and Growth Rate (2013-2018)
9.4 Egypt 5'Nucleotidase Revenue and Growth Rate (2013-2018)
9.5 Nigeria 5'Nucleotidase Revenue and Growth Rate (2013-2018)
9.6 South Africa 5'Nucleotidase Revenue and Growth Rate (2013-2018)
10 Global 5'Nucleotidase Market Segment by Type
10.1 Global 5'Nucleotidase Revenue and Market Share by Type (2013-2018)
10.2 Global 5'Nucleotidase Market Forecast by Type (2018-2023)
10.3 Single Dose Revenue Growth Rate (2013-2023)
10.4 Combination Therapy Revenue Growth Rate (2013-2023)
11 Global 5'Nucleotidase Market Segment by Application
11.1 Global 5'Nucleotidase Revenue Market Share by Application (2013-2018)
11.2 5'Nucleotidase Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)
12 Global 5'Nucleotidase Market Size Forecast (2018-2023)
12.1 Global 5'Nucleotidase Market Size Forecast (2018-2023)
12.2 Global 5'Nucleotidase Market Forecast by Regions (2018-2023)
12.3 North America 5'Nucleotidase Revenue Market Forecast (2018-2023)
12.4 Europe 5'Nucleotidase Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific 5'Nucleotidase Revenue Market Forecast (2018-2023)
12.6 South America 5'Nucleotidase Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa 5'Nucleotidase Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure 5'Nucleotidase Picture
Table Product Specifications of 5'Nucleotidase
Table Global 5'Nucleotidase and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
